Pioneering circular DNA in sequencing and diagnostics
With next-generation sequencing, we became readers of DNA.
With synthetic chemistry, we became writers of DNA.
With circular DNA, our team is transforming how information is stored and accessed on DNA.
Unified foundation for sequencing and diagnostics
In our vision, DNA sequences are no longer static records but dynamic units, capable of supporting database operations as seamlessly as today’s digital systems. This unified approach will transform sequencing applications, making DNA data more accessible, interactive, and integral to modern solutions.
Leveraging circular DNA for simplicity, specificity and high fidelity
With Geno1® technologies, we are committed to unsurpassed data quality on established as well as emerging sequencing platforms.
Deploy Geno1® technologies anywhere, on any sequencing platform, free of infrastructure constraints.
Simple and rapid
Cost-efficient
Platform-agnostic
Low-infrastructure
News
Bridge Capture™ by Genomill represents a major leap forward in liquid biopsy diagnostics
The new method will enable cost-efficient, rapid, and sensitive molecular precision diagnostics for cancer.
Genomill and Finland’s Cancer Research Flagship iCAN Partner To Improve Cancer Detection Using an Extensive Biobank Cohort
Genomill and iCAN, the Finnish national cancer research flagship project, signed a partnership aiming to improve the detection of trace tumour DNA from thousands of biobank samples.
Genomill appoints former Foundation Medicine executive and plans to present unmatched data at PMWC
Seminal presentation of first analytical validation data scheduled for june 30